Marksans Pharma Ltd.

NSE: MARKSANS | BSE: 524404 | ISIN: INE750C01026 | Industry: Pharmaceuticals
| Mid-range Performer
226.0000 -2.12 (-0.93%)
NSE Mar 25, 2025 15:31 PM
Volume: 1.7M
 

226.00
-0.93%
StoxBox - BP Wealth
Marksans Pharma has entered into a Business Transfer Agreement with Tevapharm to acquire its business relating to the manufacture and supply of bulk pharmaceutical formulations in Goa. The company plans to manufacture tablets, hard and soft gel capsules, ointments, gummies, and creams from the new capacity.
Number of FII/FPI investors increased from 125 to 149 in Dec 2024 qtr.
More from Marksans Pharma Ltd.
Recommended